[HTML][HTML] PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions
C Eze, NS Schmidt-Hegemann, LM Sawicki… - European journal of …, 2021 - Springer
Purpose The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment
of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative …
of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative …
[HTML][HTML] PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy
Y Gao, C Wu, X Chen, L Ma, X Zhang, J Chen… - Frontiers in …, 2022 - frontiersin.org
Cancer immunotherapy, especially immune-checkpoint inhibitors (ICIs), has paved a new
way for the treatment of many types of malignancies, particularly advanced-stage cancers …
way for the treatment of many types of malignancies, particularly advanced-stage cancers …
PET in the management of locally advanced and metastatic NSCLC
W Grootjans, LF de Geus-Oei, EGC Troost… - Nature reviews Clinical …, 2015 - nature.com
Despite considerable improvements in the treatment options for advanced-stage non-small-
cell lung cancer (NSCLC), disease-specific survival remains poor. With the aim of improving …
cell lung cancer (NSCLC), disease-specific survival remains poor. With the aim of improving …
Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy
Introduction Immunotherapy has improved outcomes for patients with non-small cell lung
cancer (NSCLC), yet durable clinical benefit (DCB) is experienced in only a fraction of …
cancer (NSCLC), yet durable clinical benefit (DCB) is experienced in only a fraction of …
[HTML][HTML] PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
M Unterrainer, M Ruzicka, MP Fabritius… - European radiology …, 2020 - Springer
Recent immunotherapeutic approaches have evolved as powerful treatment options with
high anti-tumour responses involving the patient's own immune system. Passive …
high anti-tumour responses involving the patient's own immune system. Passive …
[HTML][HTML] Impact of PET/CT for assessing response to immunotherapy—A clinical perspective
D Lang, G Wahl, N Poier, S Graf, D Kiesl… - Journal of Clinical …, 2020 - mdpi.com
Cancer immunotherapy using immune-checkpoint inhibitors (ICI) has revolutionized the
therapeutic landscape of various malignancies like non-small-cell lung cancer or melanoma …
therapeutic landscape of various malignancies like non-small-cell lung cancer or melanoma …
[HTML][HTML] 18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
G Polverari, F Ceci, V Bertaglia, ML Reale, O Rampado… - Cancers, 2020 - mdpi.com
Objectives:(1.1) to evaluate the association between baseline 18F-FDG PET/CT semi-
quantitative parameters of the primary lesion with progression free survival (PFS), overall …
quantitative parameters of the primary lesion with progression free survival (PFS), overall …
[HTML][HTML] Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments …
Response assessment in the context of immunomodulatory treatments represents a major
challenge for the medical imaging community and requires a multidisciplinary approach with …
challenge for the medical imaging community and requires a multidisciplinary approach with …
[HTML][HTML] Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory …
Purpose The goal of this guideline/procedure standard is to assist nuclear medicine
physicians, other nuclear medicine professionals, oncologists or other medical specialists …
physicians, other nuclear medicine professionals, oncologists or other medical specialists …
[HTML][HTML] Immunotherapy by immune checkpoint inhibitors and nuclear medicine imaging: current and future applications
Immunotherapy by using immune checkpoint inhibitors is a revolutionary development in
oncology. Medical imaging is also impacted by this new therapy, particularly nuclear …
oncology. Medical imaging is also impacted by this new therapy, particularly nuclear …